Walgreens Boots Alliance, Inc. (WBA) Shares Sold by Cim Investment Mangement Inc.

Cim Investment Mangement Inc. cut its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 8.7% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,926 shares of the pharmacy operator’s stock after selling 660 shares during the quarter. Cim Investment Mangement Inc.’s holdings in Walgreens Boots Alliance were worth $575,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently modified their holdings of the company. Hudock Capital Group LLC boosted its holdings in Walgreens Boots Alliance by 0.4% during the 1st quarter. Hudock Capital Group LLC now owns 1,300 shares of the pharmacy operator’s stock valued at $108,000 after acquiring an additional 5 shares during the period. Tarbox Group Inc. raised its position in Walgreens Boots Alliance by 288.3% during the 1st quarter. Tarbox Group Inc. now owns 1,355 shares of the pharmacy operator’s stock valued at $113,000 after purchasing an additional 1,006 shares during the last quarter. Webster Bank N. A. raised its position in Walgreens Boots Alliance by 18.4% during the 1st quarter. Webster Bank N. A. now owns 1,509 shares of the pharmacy operator’s stock valued at $125,000 after purchasing an additional 235 shares during the last quarter. MCF Advisors LLC raised its position in Walgreens Boots Alliance by 68.2% during the 1st quarter. MCF Advisors LLC now owns 1,923 shares of the pharmacy operator’s stock valued at $160,000 after purchasing an additional 780 shares during the last quarter. Finally, Founders Capital Management bought a new position in Walgreens Boots Alliance during the 1st quarter valued at approximately $161,000. Institutional investors own 60.16% of the company’s stock.

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) opened at 78.41 on Friday. The company’s 50-day moving average price is $81.36 and its 200-day moving average price is $81.86. The company has a market cap of $83.91 billion, a price-to-earnings ratio of 19.80 and a beta of 1.26. Walgreens Boots Alliance, Inc. has a 52-week low of $75.18 and a 52-week high of $89.69.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Thursday, June 29th. The pharmacy operator reported $1.33 EPS for the quarter, topping analysts’ consensus estimates of $1.30 by $0.03. The company had revenue of $30.12 billion during the quarter, compared to the consensus estimate of $29.72 billion. Walgreens Boots Alliance had a net margin of 3.69% and a return on equity of 17.34%. Walgreens Boots Alliance’s revenue for the quarter was up 2.1% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.18 earnings per share. Equities research analysts expect that Walgreens Boots Alliance, Inc. will post $5.00 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 12th. Investors of record on Friday, August 18th were paid a $0.40 dividend. This is an increase from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. The ex-dividend date of this dividend was Wednesday, August 16th. This represents a $1.60 dividend on an annualized basis and a yield of 2.04%. Walgreens Boots Alliance’s payout ratio is 40.30%.

Walgreens Boots Alliance declared that its Board of Directors has initiated a share repurchase program on Thursday, June 29th that allows the company to buyback $5.00 billion in outstanding shares. This buyback authorization allows the pharmacy operator to repurchase up to 5.9% of its shares through open market purchases. Shares buyback programs are typically an indication that the company’s management believes its stock is undervalued.

TRADEMARK VIOLATION WARNING: This piece was originally reported by BBNS and is owned by of BBNS. If you are accessing this piece on another site, it was illegally stolen and republished in violation of international copyright laws. The original version of this piece can be viewed at https://baseballnewssource.com/markets/walgreens-boots-alliance-inc-wba-shares-sold-by-cim-investment-mangement-inc/1604547.html.

In related news, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction that occurred on Tuesday, July 25th. The shares were sold at an average price of $79.79, for a total value of $218,305.44. Following the completion of the transaction, the director now owns 19,151 shares of the company’s stock, valued at $1,528,058.29. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 13.50% of the company’s stock.

WBA has been the subject of a number of recent analyst reports. Needham & Company LLC raised Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $94.00 price target for the company in a research report on Friday, June 30th. Pivotal Research set a $85.00 price target on Walgreens Boots Alliance and gave the company a “hold” rating in a research report on Sunday, July 2nd. Zacks Investment Research lowered Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research report on Wednesday, June 14th. BidaskClub raised Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research report on Wednesday, August 30th. Finally, Goldman Sachs Group, Inc. (The) reissued a “neutral” rating and issued a $77.00 target price (down previously from $89.00) on shares of Walgreens Boots Alliance in a research report on Wednesday, June 28th. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating and fifteen have assigned a buy rating to the stock. The stock has an average rating of “Buy” and a consensus price target of $92.06.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with our FREE daily email newsletter.

 


Latest News

American League Once Again Dominates National League
American League Once Again Dominates National League
Los Angeles Dodgers Waiting But Magic Number Down to One
Los Angeles Dodgers Waiting But Magic Number Down to One
Young Girl Hit by Foul Ball Rushed to Hospital
Young Girl Hit by Foul Ball Rushed to Hospital
New Home Run Record Reached in Major League Baseball
New Home Run Record Reached in Major League Baseball
Will 2017 MLB Season End with No 20-Game Winner?
Will 2017 MLB Season End with No 20-Game Winner?
Cleveland Indians Winning Streak Snapped at 22
Cleveland Indians Winning Streak Snapped at 22


Leave a Reply

 
© 2006-2017 BBNS.